Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

ATWLPPR Peptide (TFA)

ATWLPPR Peptide TFA, a heptapeptide, acts as a selective neuropilin-1 inhibitor, inhibits VEGF165 binding to NRP-1, used in the research of angiogenesis[1]. ATWLPPR Peptide TFA has potential in reducing the early retinal damage caused by diabetes[2].

Product Specifications

UNSPSC

12352005

Target

Complement System

Type

Reference compound

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Metabolic Disease; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/ATWLPPR_Peptide_TFA.html

Purity

99.81

Solubility

H2O : 100 mg/mL (ultrasonic)

Smiles

O=C(N[C@@H]([C@H](O)C)C(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@@H](CC(C)C)C(N3[C@@H](CCC3)C(N4[C@@H](CCC4)C(N[C@@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)[C@H](C)N.OC(C(F)(F)F)=O

Molecular Formula

C42H62F3N11O11

Molecular Weight

954.00

References & Citations

[1]Starzec A, et al. Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF (165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex. Peptides. 2007 Dec;28 (12) :2397-402.|[2]Wang J, et al. The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress. PLoS One. 2015 Nov 10;10 (11) :e0142571.

Shipping Conditions

Blue Ice

Storage Conditions

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Lysis-EZ K, Red Blood Cell (RBC) Lysis Buffer, 2x Strength Solution
PL012 100ml

Lysis-EZ K, Red Blood Cell (RBC) Lysis Buffer, 2x Strength Solution

Sign In for Pricing
View Details
OR8H3 CRISPR/Cas9 KO Plasmid (h)
sc-416470 20 µg

OR8H3 CRISPR/Cas9 KO Plasmid (h)

Sign In for Pricing
View Details
Recombinant Saccharomyces cerevisiae Probable serine/threonine-protein kinase COQ8, mitochondrial (COQ8)
MBS1023781-01 0.02 mg (E-Coli)

Recombinant Saccharomyces cerevisiae Probable serine/threonine-protein kinase COQ8, mitochondrial (COQ8)

Sign In for Pricing
View Details
Recombinant Saccharomyces cerevisiae Probable serine/threonine-protein kinase COQ8, mitochondrial (COQ8)
MBS1023781-02 0.02 mg (Yeast)

Recombinant Saccharomyces cerevisiae Probable serine/threonine-protein kinase COQ8, mitochondrial (COQ8)

Sign In for Pricing
View Details
Recombinant Saccharomyces cerevisiae Probable serine/threonine-protein kinase COQ8, mitochondrial (COQ8)
MBS1023781-03 0.1 mg (E-Coli)

Recombinant Saccharomyces cerevisiae Probable serine/threonine-protein kinase COQ8, mitochondrial (COQ8)

Sign In for Pricing
View Details
Recombinant Saccharomyces cerevisiae Probable serine/threonine-protein kinase COQ8, mitochondrial (COQ8)
MBS1023781-04 0.1 mg (Yeast)

Recombinant Saccharomyces cerevisiae Probable serine/threonine-protein kinase COQ8, mitochondrial (COQ8)

Sign In for Pricing
View Details